Factor This Power Engineering
Live Events
DTECH® Events
POWERGENâ¢
Calendar
Webinars
Podcasts
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
Podcasts
Webinars
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Hydroworld Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Revvity, Inc. Common Stock
(NY:
RVTY
)
103.63
+0.81 (+0.79%)
Streaming Delayed Price
Updated: 10:00 AM EST, Feb 10, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Revvity, Inc. Common Stock
< Previous
1
2
3
Next >
Revvity Unveils New High-Impact Discovery Platforms and Showcases Recent Innovations at SLAS2026
February 05, 2026
From
Revvity
Via
Business Wire
Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2025
February 02, 2026
From
Revvity
Via
Business Wire
Revvity Board Declares Quarterly Dividend
January 26, 2026
From
Revvity
Via
Business Wire
Revvity to Hold Earnings Call on Monday, February 2, 2026; Provides Update on Financial Performance
January 12, 2026
From
Revvity
Via
Business Wire
Revvity to Present at J.P. Morgan Healthcare Conference
December 18, 2025
From
Revvity
Via
Business Wire
Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models
January 09, 2026
From
Revvity
Via
Business Wire
Revvity to Acquire ACD/Labs to Expand its Signals Software Capabilities
November 10, 2025
From
Revvity
Via
Business Wire
Revvity to Present at Upcoming Investor Conferences
October 28, 2025
From
Revvity
Via
Business Wire
Revvity Announces Financial Results for the Third Quarter of 2025
October 27, 2025
From
Revvity
Via
Business Wire
Revvity Board Declares Quarterly Dividend
October 23, 2025
From
Revvity
Via
Business Wire
Revvity Showcases Progress with Purpose in 2025 Impact Report
October 14, 2025
From
Revvity
Via
Business Wire
Revvity to Hold Earnings Call on Monday, October 27, 2025
October 06, 2025
From
Revvity
Via
Business Wire
Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes
October 02, 2025
From
Revvity
Via
Business Wire
Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis
September 29, 2025
From
Revvity
Via
Business Wire
Revvity and Profluent Collaborate to Launch AI-Enhanced Adenine Deaminase Pin-point Base Editing Systems
September 22, 2025
From
Revvity
Via
Business Wire
Revvity Establishes In Vivo Imaging Center of Excellence in North Carolina
September 02, 2025
From
Revvity
Via
Business Wire
Revvity to Present at Upcoming Investor Conferences
August 18, 2025
From
Revvity
Via
Business Wire
Revvity Launches Innovative Reagent Technology to Accelerate Development of Next-Generation Targeted Therapeutics
August 06, 2025
From
Revvity
Via
Business Wire
Revvity Announces Financial Results for the Second Quarter of 2025
July 28, 2025
From
Revvity
Via
Business Wire
Revvity Board Declares Quarterly Dividend
July 24, 2025
From
Revvity
Via
Business Wire
Revvity to Hold Earnings Call on Monday, July 28, 2025
July 07, 2025
From
Revvity
Via
Business Wire
Revvity Introduces New IVD Reference Standards for Monitoring Oncology Diagnostic Testing Workflows
June 02, 2025
From
Revvity
Via
Business Wire
Revvity’s EUROIMMUN Unveils New Fully Automated Instrument for Specialty Testing
May 19, 2025
From
Revvity
Via
Business Wire
Revvity to Present at Upcoming Investor Conferences
April 30, 2025
From
Revvity
Via
Business Wire
Revvity Announces Financial Results for the First Quarter of 2025
April 28, 2025
From
Revvity
Via
Business Wire
Revvity Board Declares Quarterly Dividend
April 24, 2025
From
Revvity
Via
Business Wire
Revvity to Hold Earnings Call on Monday, April 28, 2025
April 03, 2025
From
Revvity
Via
Business Wire
Revvity Secures FDA Approval for Improved Automated Latent Tuberculosis Test
April 02, 2025
From
Revvity
Via
Business Wire
Revvity’s EUROIMMUN Receives CE Mark for Novel Measles Antibody Detection Assay
March 03, 2025
From
Revvity
Via
Business Wire
Revvity Expands Alliance with Genomics England to Drive Research into Newborn Genomic Sequencing in England
March 20, 2025
From
Revvity
Via
Business Wire
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
